HIP2105
/ Hanmi
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 25, 2023
Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=48 | Completed | Sponsor: Hanmi Pharmaceutical Company Limited | Recruiting ➔ Completed
Trial completion
July 23, 2021
Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers
(clinicaltrials.gov)
- P1; N=48; Recruiting; Sponsor: Hanmi Pharmaceutical Company Limited
New P1 trial
1 to 2
Of
2
Go to page
1